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  A nonspecific cellular immunity was measured by PHA induced blastogenesis of lymphocytes
in the patients having bladder carcinoma． Peripheral lymphocytes counts of the patients was almbst
same as the age matched tumor－free patients． However， blastogenesis of lymphocytes with autolog－
ous serum was depressed as compared with age matched tumor－free patients． There was a significant
converse correlation in lymphocytes blastogenesis te the grade and the stage of the tumor．
  Thus， two considerable factors ： cellular and humoral factors were suggested to inhibit blastogenesis
of lymphocytes in the patients with bladder caricnoma．
  Regarding cellular factor， a study was made on lymphocytes subpopulation of 23 patients with・
bladder carcinoma and of 11 age matched tumor－free patients． ldentification of lymphocytes was
performed by means of rosette formation with sheep erythrocytes． T－cell was identified by spon－
taneous rosette formation with sheep erythrocytes （E－rosette）， and B－cell was identified by EAC－
rosette formation．
  There was a tendency of decrease in percentage and absolute count of T－cell in the patients
with higher grade and stage of the tumor．
  Contrary， percentage of B－cell in the patients with tumor was significantly higher than that of
tumor－free patients．
  However， percentage of B－cell was not correlated to the grade and stage of the tumor．















り2・3），骨髄由来リンパ球（bone marrQw dcrived cell，
以下B－ccllと略す）はPHAに対してはほとんど反
応しないと考えら．れている4）．そこで今回はまず第1
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の要因を調べる目的で膀胱癌患者末梢血リンパ球の
subpopulationを調べ若干の成績を得たので報告する．
          対象および実験方法
 1）対 象
 対象は大阪市立大学附属病院泌尿器科に入院した膀
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       Age Male Female
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      70一・79 6 1
      80－89 1 O
      雪9主量1＿＿＿＿＿29＿．．一＿＿⊇＿＿＿
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      CONTRO工」PAT工ENTS
   D工SEASE            CASES
 Renal Calculus 3Hypertension 2
Ureteral Calculus 2
Urethral Stricture 1
1’otal ll （BPH ： Benign Prostatic Hypertrophy）
sex ： male 7 and female 4 cases
mean age ： 61．9 years old
         熱・勤繍灘
       Method
Heparinized blood 2 ml
               2 ml
   （Ficoll－Conray）
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grade I， II， III， IVの4段階に区分し，浸潤度は
Jcwett6）and Marshal17）の分類にしたがいstage A，
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は認めない． Fig．8はlow grade群とhigh grade
群についてT・ce11数を比較したもので，平均値は10w

























OF T－CELL POPULATION OFLYMPHOCYTES
































































T－CELL POPULATION INBLADDER TUMOR
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COMPARfSON OF T－CELL COUNTS iN
PATIENTS WITH BLADDER TUMOR


































































COMPARISON OF B－CELL POPULATION INPATIENTS WITH BLADDER TUMOR


































COMPARISON OF B－CELL POPULATION INPATIENTS WITH BLADDER TUMOR



















































CCt／fiPARISON OF B－CELL COUNTS irri
PATIENTS WITH BLADDER TUMOR．
                     （Grade｝
COMPARISON OF B－CELL COUNT＄ IN
PATIENTS・WITH BLADDER TUMOR


















































































皿m3， high grade群1214±337 cells／mm3と二者の
間にはほとんど差を認めない．同様にlow stage群と
high stage群とのB－cell数を比較すると， Fig・15に
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